SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- pain
An SI Board Since December 2001
Posts SubjectMarks Bans
101 19 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
26Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11165-9. Epub 2004 Jul 19. Acetascaram(o)uche-9/5/2004
25Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM) nigel bates-7/15/2004
24NicOx's HCT 3012 Shows Equivalent Efficacy to Rofecoxib Without Any Increasenigel bates-6/10/2004
23POZEN / Trexima - $15m milestone from GSK for PIII start. CHAPEL HILL & RESnigel bates-5/18/2004
22>> TRPV1 << more..... Message 20088802scaram(o)uche-5/10/2004
21J Neurosci. 2004 Apr 7;24(14):3663-71. Direct Interaction of Adenosine with tscaram(o)uche-4/9/2004
20Painkilling patch works like needle delivery-study Tuesday March 16, 3:58 pm ET keokalani'nui-3/16/2004
19International Wex Technologies Inc. ('Wex'or the 'Company') is prusset-12/4/2003
18J Pharmacol Exp Ther. 2003 Oct 16 [Epub ahead of print]. Anticociceptive effescaram(o)uche-10/19/2003
17Results from POZEN Phase IIIb Study Show Early Treatment with MT 100 Improves Efnigel bates-9/24/2003
16not on pain, but relevant to "Cheech and Chong on the History of Medical Rescaram(o)uche-9/8/2003
15And it comes out of Tucson, home of epitan et al. Cool. There are millions of scaram(o)uche-8/19/2003
14[CB2 cannabinoid receptor agonist -- U. of Arizona (Roche with a toehold?)] Pubtuck-8/19/2003
13[Anti CCR2 -- Merck] >>Published online before print June 13, 2003 Proc. tuck-6/13/2003
12GSK / POZN / $25-80m migraine deal RESEARCH TRIANGLE PARK & CHAPEL HILL, N.nigel bates-6/12/2003
11Na ion channel blocker protein toxin from pufferfish,... early studies from paterusset-4/19/2003
10Retargeting Botox - Interesting story from the New Scientist: <i>Combininigel bates-4/17/2003
9Study: Back Pain Linked to Brain Shrinkage Fri Mar 21, 9:13 PM ET NEW YORK (Reunigel bates-3/24/2003
8LAVAL, QC, Jan. 22 /CNW/ - Labopharm Inc. (TSX: DDS) today announced positive rerusset-1/23/2003
7Labopharm Initiates U.S. Phase III Clinical Trials for Once-Daily Tramadol russet-1/13/2003
6[Abbott - P2X3 and P2X2/3 receptor antagonist] Published online before print Detuck-12/15/2002
5Kiadis / Biofrontera Pharmaceuticals sign major joint drug discovery and developnigel bates-11/29/2002
4Acetaminophen / COX-3 Mon Sep 16 NEW YORK (Reuters Health) - Acetaminophen, benigel bates-9/17/2002
3Morphine effectiveness restored to between 80 and 90% of original amount (Kingsnigel bates-2/1/2002
2[ PTIE/narcotic ] Tuesday December 11, 3:00 pm Eastern Time Press Release SOURCscaram(o)uche-12/12/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News